Business · 27/12/2013Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of New Animal Drug Applications for Roxarsone
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of five new animal drug applications for roxarsone oral dosage form products, following a request from the sponsor due to the products no longer being manufactured or marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →